Cargando…
Insulin/carbohydrates ratio during the first 6‐month therapy with insulin degludec in a paediatric population with type 1 diabetes previously treated with insulin glargine. An observational longitudinal study
BACKGROUND: No data exist about the changes induced by the transition from first‐generation long‐acting insulins to second‐generation long‐acting analogues in the paediatric population. OBJECTIVE: To assess changes in insulin/carbohydrate ratio (I:CHO) after the first 6 months of degludec therapy in...
Autores principales: | Tumini, Stefano, Iacono, Olimpia, Comegna, Laura, Fioretti, Elisabetta, Guidone, Paola, Levantini, Gabriella, Panichi, Daniele, Catenaro, Milena, Rossi, Ilaria, Amaro, Flavia, Graziano, Giusi, Rossi, Maria Chiara, Cipriano, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170455/ https://www.ncbi.nlm.nih.gov/pubmed/32318639 http://dx.doi.org/10.1002/edm2.121 |
Ejemplares similares
-
Effectiveness and safety of flexible therapeutic schemes including first- and secondgeneration basal insulins during a pediatric summer diabetes camp
por: Tumini, Stefano, et al.
Publicado: (2020) -
Glargine and degludec: Solution behaviour of higher dose synthetic insulins
por: Adams, Gary G., et al.
Publicado: (2017) -
Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
por: Buscemi, Silvio, et al.
Publicado: (2019) -
Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes
por: Home, P D, et al.
Publicado: (2012) -
Response to insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
por: Yamabe, Mizuho
Publicado: (2019)